Advertisement

Foamy Viruses pp 161-180 | Cite as

Replication of Primate Foamy Viruses in Natural and Experimental Hosts

Chapter
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 277)

Abstract

Foamy viruses (FVs) are common apathogenic retroviruses readily spread by horizontal transmission in nonhuman primate and some other mammalian host populations. Primate FV infections have been known for half a century, i.e., 15 years before the definition of retroviruses and another 15 years before the detection of primate immune deficiency viruses. The emerging interest in human retroviruses

Keywords

World Monkey Foamy Virus Experimental Host Foamy Virus Prototype Simian Foamy Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Achong BG, Mansell PWA, Epstein MA, Clifford P (1971) An unusual virus in cul-tures from a human nasopharyngeal carcinoma. J Nail Cancer Inst 46:299–302Google Scholar
  2. Aguzzi A (1993) The foamy virus family molecular biology, epidemiology and neu-ropathology. Biochim Biophys Acta 1155:124Google Scholar
  3. Aguzzi A, Marino S, Tschopp R, Rethwilm A (1996) Regulation of expression and pathogenic potential of human foamy virus in vitro and in transgenic mice. Curr Top Microbiol Immunol 206:243–273PubMedCrossRefGoogle Scholar
  4. Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, McClure MO (1995a) A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology 207:217–228CrossRefGoogle Scholar
  5. Bieniasz PD, Weiss RA, McClure MO (1995b) Cell cycle dependence of foamy retro-virus infection. J Virol 69: 7295–7299Google Scholar
  6. Blewett EL, Black DH, Lerche NW, White G, Eberle R (2000) SFV infection in a baboon breeding colony. Virology 278:183–193PubMedCrossRefGoogle Scholar
  7. Bock M, Heinkelein M, Lindemann D, Rethwilm A (1998) Cells expressing the human foamyvirus (HFV) accessory bet protein are resistant to productive HFV superinfection. Virology 250:194–204PubMedCrossRefGoogle Scholar
  8. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I (1991) Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253:555–557PubMedCrossRefGoogle Scholar
  9. Broussard SR, Comuzzie AG, Leighton KL, Leland MM, Whitehead EM, Allan JS (1997) Characterization of new simian foamy viruses from African nonhuman primates. Virology 237: 349–59PubMedCrossRefGoogle Scholar
  10. Brown P, Morreau-Dubois C, Gajdusek DC (1982) Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retroviral latency. Arch Virol 71: 229–234PubMedCrossRefGoogle Scholar
  11. Callahan ME, Switzer WM, Matthews AL, Roberts BD, Heneine W, Folks TM, Sandstrom PA (1999) Persistent zoonotic infection of a human with a simian foamy virus in the absence of an intact orf-2 accessory gene. J Virol 73:9619–24PubMedGoogle Scholar
  12. Cameron, KR, Birchall SM, Moses, MA (1978) Isolation of foamy virus from patient with dialysis encephalopathy. Lancet II:796CrossRefGoogle Scholar
  13. Carski T (1960) A fluorescent antibody study of the simian foamy agent. J Immunol 84: 426–433PubMedGoogle Scholar
  14. Colas S, Bourge JF, Wybier J, Chelbi-Alix MK, Paul P, Emanoil-Ravier R (1995) Human foamy virus infection activates class I major histocompatibility complex antigen expression. J Gen Virol 76:661–667PubMedCrossRefGoogle Scholar
  15. Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86:277–286PubMedGoogle Scholar
  16. Falcone V, Leupold J, Clotten J, Urbanyi E, Herchenroeder O, Spatz W, Volk B, Boehm N, Toniolo A, Neumann-Haefelin D, Schweizer M (1999a) Sites of simian foamy virus persistence in naturally infected African green monkeys: latent pro-virus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257:7–14CrossRefGoogle Scholar
  17. Falcone V, Schweizer M, Toniolo A, Neumann-Haefelin D, Meyerhans A (1999b) Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects. J Virol 73:1724–1728Google Scholar
  18. Feldman MD, Dunnick NR, Barry DW, Paerkman PD (1975) Isolation of foamy virus from rhesus, African green and cynomolgus monkey leukocytes. J Med Primatol 4:287–295PubMedGoogle Scholar
  19. Felsenstein J (1989) PHYLIP (phylogeny inference package) version 3.2. Cladistics 5:164–166Google Scholar
  20. Fleming WA, Clarke JK (1970) Fluorescence assay of foamy virus. J Gen Virol 6:277–284PubMedCrossRefGoogle Scholar
  21. Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure M, Rethwilm A (1994) Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol 75:2635–2644PubMedCrossRefGoogle Scholar
  22. Heneine W, Switzer WM, Sandstrom P, Brown J, Shanmugam V, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks, TM (1998) Identification of a human population infected with simian foamy virus. Nat Med 4:403–407PubMedCrossRefGoogle Scholar
  23. Hirata RK, Miller AD, Andrews RG, Russell DW (1996) Transduction of hematopoietic cells by foamy virus vectors. Blood 88:3654–61PubMedGoogle Scholar
  24. Hirsch VM, Dapolito G, Goeken R, Campbell BJ (1995) Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr Opin Genet Dev 5:798–806PubMedCrossRefGoogle Scholar
  25. Hooks JJ, Burns W, Hayashi K, Geis S, Notkins AL (1976) Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun 14:1172–1178PubMedGoogle Scholar
  26. Hooks JJ, Gibbs CJ, Chou R, Howk R, Lewis M, Gajdusek DC (1973) Isolation of a new simian foamy virus from a spider monkey brain culture. Infect Immun 8:804–813PubMedGoogle Scholar
  27. Hooks JJ, Gibbs CJ, Cutchins EC, Rogers NG, Lampert P, Gajdusek DC (1972) Characterization and distribution of two new foamy viruses isolated from chimpanzees. Arch Ges Virusforsch 38:38–55PubMedCrossRefGoogle Scholar
  28. Hooks JJ, Gibbs CJ (1975) The foamy viruses. Bacteriol Rev 39:169–185PubMedGoogle Scholar
  29. Hooks JJ, Detrick-Hooks B (1979) Simian foamy virus-induced immunosuppression in rabbits. J Gen Virol 44: 383–390PubMedCrossRefGoogle Scholar
  30. Howcroft TK, Strebel K, Martin MA, Singer DS (1993) Repression of MHC-1 gene promoter activity by two-exon tat of HIV. Science 260:1320–1322PubMedCrossRefGoogle Scholar
  31. Imrich H, Müller JG, Lindemann D, Heinkelein M, Rethwilm A (2003) Pathogenicity of Foamy Virus in arhymic mice. (Submitted)Google Scholar
  32. Johnston PB (1961) A second immunological type of simian foamy virus: monkey throat infection and unmasking by both types. J Infect Dis 109:1–9PubMedCrossRefGoogle Scholar
  33. Johnston PB (1971) Taxonomic features of seven serotypes of simian and ape foamy viruses. Infect Immun 3:793–799PubMedGoogle Scholar
  34. Johnston PB (1974) Studies on simian foamy viruses and syncytium-forming viruses of lower animals. Lab Anim Sci 24:159–166PubMedGoogle Scholar
  35. Kralli A, Ge R, Graeven U, Ricciardi RP, Weinmann R (1992) Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element. J Virol 66:6979–6988PubMedGoogle Scholar
  36. Lecellier CH, Saïb A (2000) Foamy viruses: Between retroviruses and pararetrovirus-es. Virology 271:1–8PubMedCrossRefGoogle Scholar
  37. Linial M (2000) Why aren’t foamy viruses pathogenic? Trends Microbiol 289:284–289CrossRefGoogle Scholar
  38. Linial ML (1999) Foamy viruses are unconventional retroviruses. J Virol 73:1747–1755PubMedGoogle Scholar
  39. McClure MO, Bieniasz PD, Schulz TF, Chrystie IL, Simpson G, Aguzzi A, Hoad JG, Cunningham A, Kirkwood J, Weiss RA (1994) Isolation of a new foamy retrovirus from orangutans. J Virol 68:7124–7130PubMedGoogle Scholar
  40. McClure MO, Erlwein 0 (1995) Foamy viruses-pathogenic or therapeutic potential. Rev Med Virol 5: 229–237CrossRefGoogle Scholar
  41. Meiering CD, Linial ML (2001) Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 14:165–176PubMedCrossRefGoogle Scholar
  42. Mergia A, Chan S, Kolson DL, Goodenow MM, Ciccarone T (2001) The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and human PBLs. Virology 280:243–252PubMedCrossRefGoogle Scholar
  43. Mergia A, Leung NJ, Blackwell J (1996) Cell tropism of the simian foamy virus type 1 (SFV-1). J Med Primatol 25:2–7PubMedCrossRefGoogle Scholar
  44. Mikovits JA, Hoffman PM, Rethwilm A, Ruscetti FW (1996) In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J Virol 70: 2774–2780PubMedGoogle Scholar
  45. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993) Foamy viruses. Intervirology 35:196–207PubMedGoogle Scholar
  46. Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, zur Hausen H (1983) Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 172:75–86PubMedCrossRefGoogle Scholar
  47. Parks WP, Todaro GJ, Scolnick EM, Aaronson SA (1971) RNA dependent DNA poly-merase in primate syncytium-forming (foamy) viruses. Nature 229:258–260PubMedCrossRefGoogle Scholar
  48. Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, de Thé H, Chelbi-Mix MK (2001) PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20:3495–3505PubMedCrossRefGoogle Scholar
  49. Rhodes-Feuillette A, Lasneret J, Paulien S, Ogunkolade W, Périès J, Canivet M (1990) Effects of human recombinant alpha and gamma and that of highly purified natural beta interferons on simian spumavirinae prototype (simian foamy virus 1) multiplication in human cells. Res Virol 141:31–43PubMedCrossRefGoogle Scholar
  50. Rhodes-Feuillette A, Saal F, Lasnaret J, Dubouch P, Périès J (1979) Isolation and characterization of a new simian foamy virus serotype from lymphocytes of a Papio cynocephalus baboon. J Med Primatol 8:308–320PubMedGoogle Scholar
  51. Rhodes-Feuillette A, Saal F, Lasneret J, Santillana-Hayat M, Périès J (1987) Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses. Arch Virol 97:77–84PubMedCrossRefGoogle Scholar
  52. Rogers N, Basnight M, Gibbs GJ, Gajdusek DC (1967) Latent viruses in chimpanzees with experimental kuru. Nature 216:446–449PubMedCrossRefGoogle Scholar
  53. Rösener M, Hahn H, Kranz M, Heeney J, Rethwilm A (1996) Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 48:222–226PubMedCrossRefGoogle Scholar
  54. Rustigian R, Johnston P, Reihart, H (1955) Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med 88:8–16PubMedGoogle Scholar
  55. Sabile A, Rhodes-Feuillette A, Jaoui FZ, Tobaly-Tapiero J, Giron ML, Lasneret J, Périès J, Canivet M (1996) In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus. Res Virol 147:29–37PubMedCrossRefGoogle Scholar
  56. Saib A, Koken HM, van der Spek P, Périès J, de Thé H (1995b) Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol 69:5261–5268Google Scholar
  57. Saib A, Neves M, Giron ML, Guillemin MC, Valla J, Périès J, Canivet M (1997) Longterm persistent infection of domestic rabbits by the human foamy virus. Virology 228:263–268PubMedCrossRefGoogle Scholar
  58. Saib A, Périès J, de Thé H (1995a) Recent insights into the biology of the human foamy virus. Trends Microbio1:173–178CrossRefGoogle Scholar
  59. Saib A, Périès J, de Thé H (1993) A defective human foamy provirus generated by pregenome splicing. EMBO J 12:4439–4444PubMedGoogle Scholar
  60. Santillana-Hayat M, Rozain F, Bittoun P, Chopin-Robert C, Lasneret J, Périès J Canivet M (1993) Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res Virol 144:389–396PubMedCrossRefGoogle Scholar
  61. Sawada M, Suzumura A, Yoshida M, Marunouchi T (1990) Human T-cell leukemia virus type 1 transactivator induces class I major histocompatibility complex antigen expression in glial cells. J Virol 64:4002–4006PubMedGoogle Scholar
  62. Schmidt M, Niewiesk S, Heeney J, Aguzzi A, Rethwilm A (1997) Mouse model to study the replication of primate foamy viruses. J Gen Virol 78: 1929–1933PubMedGoogle Scholar
  63. Schweizer M, Corsten B, Neumann-Haefelin D (1988) Heterogeneity of primate foamy virus genomes. Arch Virol 99:125–134PubMedCrossRefGoogle Scholar
  64. Schweizer M, Falcone V, Gaenge J, Turek R, Neumann-Haefelin D (1997) Simian foamy virus isolated from an accidentally infected human individual. J Virol 71:4821–4824PubMedGoogle Scholar
  65. Schweizer M, Fleps U, Jaeckle A, Renne R, Turek R, Neumann-Haefelin D (1993) Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: Reactivation by demethylation of proviral DNA. Virology 192:663–666PubMedCrossRefGoogle Scholar
  66. Schweizer M, Neumann-Haefelin D (1995) Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577–582PubMedCrossRefGoogle Scholar
  67. Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neumann-Haefelin D (1999). Genetic stability of foamy viruses: long-term study in an African green monkey population. J Virol 73:9256–9265PubMedGoogle Scholar
  68. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995) Markers of foamy virus (FV) infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected FIT prevalence in man AIDS Res Hum Retrovir 11:161–170Google Scholar
  69. Scolnick E, Rands E, Aaronson SA, Todaro GJ (1970) RNA-dependent DNA polymer-ase activity in five RNA viruses: Divalent cation requirements. Proc Natl Acad SCI USA 67:1789–1796PubMedCrossRefGoogle Scholar
  70. Stiles GE, Bittle JL, Cabasso UJ (1964) Comparison of simian foamy virus strains including a new serological type. Nature 201:1350–1351PubMedCrossRefGoogle Scholar
  71. Swack NS, Hsiung GD (1975) Pathogenesis of simian foamy virus infection in natural and experimental hosts. Infect Immun 12:470–474PubMedGoogle Scholar
  72. von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M (1996) Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 221:240–244CrossRefGoogle Scholar
  73. Voss G, Nick S, Stahl-Hennig C, Ritter K, Hunsmann G (1992) Generation of macaque B-lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J Virol Methods 39:185–195PubMedCrossRefGoogle Scholar
  74. Weiss RA (1988) Foamy retroviruses. A virus in search of a disease. Nature 333:497–498PubMedCrossRefGoogle Scholar
  75. Weiss RA (1996) Foamy viruses bubble on. Nature 380: 201PubMedCrossRefGoogle Scholar
  76. Westarp ME, Fuchs D, Bartmann P, Hoff-Jorgensen R, Clausen J, Wachter H, Kornhuber HH (1993) Amyotrophic lateral sclerosis: an enigmatic disease with B-cellular and anti-retroviral immune responses. Eur J Med 2:327–332PubMedGoogle Scholar
  77. Wybier-Franqui J, Tobaly-Tapiero J, Coronel A, Giron ML, Chopin-Robert C, Périès J, Emanoil-Ravier R (1995) Human foamy virus DNA forms and expression in persistently infected Dami megakaryocytic cells. AIDS Res Hum Retrovir 11:829–36PubMedCrossRefGoogle Scholar
  78. Yu SF, Stone J, Linial ML (1996) Productive persistent infection of hematopoietic cells by human foamy virus. J Virol 70:1250–1254PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  1. 1.Department of Virology, Institute for Medical Microbiology and HygieneUniversity of FreiburgFreiburgGermany
  2. 2.Department of Medical BiotechnologyPaul Ehrlich InstituteLangenGermany

Personalised recommendations